Previous Close | 0.3700 |
Open | 0.3750 |
Bid | 0.3600 x 0 |
Ask | 0.3700 x 0 |
Day's Range | 0.3750 - 0.3750 |
52 Week Range | 0.3000 - 0.6900 |
Volume | |
Avg. Volume | 55,744 |
Market Cap | 51.427M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Sept 02, 1999 |
1y Target Est | N/A |
$ 1.68 Million in Funding for Capabilities and Capacity ExpansionsMISSISSAUGA, Ontario, March 20, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products relating to diagnostic testing for infectious diseases. The Government of Ontario is supporting the expansions at Microbix’s three adjac
QAPs used in Diagnostic Testing for STIs in Remote CommunitiesMISSISSAUGA, Ontario, March 01, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its Quality Assessment Products (“QAPs™”) are now supporting test accuracy within a program to provide Point-of-Care Testing (“PoCT”) for Sexually-Transmitted Infections (“STIs”) in remote communities across Australia. An initial supply of QAPs has
Using Shareholder-Approved Plan to Incentivize and RetainMISSISSAUGA, Ontario, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers. Details of the Option Issuance In con